Pinnacle Bancorp’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$134K Buy
958
+129
+16% +$18.1K 0.04% 291
2025
Q4
$102K Hold
829
0.03% 328
2025
Q3
$92K Hold
829
0.03% 339
2025
Q2
$91.9K Sell
829
-16
-2% -$1.7K 0.03% 330
2025
Q1
$94.7K Sell
845
-692
-45% -$71.4K 0.03% 320
2024
Q4
$142K Hold
1,537
0.05% 262
2024
Q3
$129K Hold
1,537
0.03% 265
2024
Q2
$105K Hold
1,537
0.03% 271
2024
Q1
$113K Hold
1,537
0.03% 267
2023
Q4
$125K Sell
1,537
-399
-21% -$31K 0.04% 242
2023
Q3
$145K Hold
1,936
0.05% 214
2023
Q2
$149K Buy
1,936
+1,039
+116% +$82.9K 0.05% 217
2023
Q1
$74.4K Buy
897
+154
+21% +$12.8K 0.03% 301
2022
Q4
$64K Sell
743
-180
-20% -$14.3K 0.02% 305
2022
Q3
$57K Hold
923
0.02% 309
2022
Q2
$57K Sell
923
-259
-22% -$16K 0.02% 316
2022
Q1
$70K Buy
1,182
+259
+28% +$16.6K 0.02% 299
2021
Q4
$67K Hold
923
0.02% 310
2021
Q3
$64K Hold
923
0.03% 307
2021
Q2
$64K Hold
923
0.03% 308
2021
Q1
$60K Buy
923
+493
+115% +$31.8K 0.03% 305
2020
Q4
$25K Sell
430
-122
-22% -$7.36K 0.02% 434
2020
Q3
$35K Buy
552
+89
+19% +$6.17K 0.02% 354
2020
Q2
$36K Hold
463
0.03% 330
2020
Q1
$35K Sell
463
-300
-39% -$20.7K 0.03% 307
2019
Q4
$50K Sell
763
-85
-10% -$5.54K 0.03% 304
2019
Q3
$54K Hold
848
0.03% 284
2019
Q2
$57K Buy
848
+77
+10% +$5.07K 0.03% 280
2019
Q1
$50K Hold
771
0.03% 297
2018
Q4
$48K Buy
+771
New +$53.9K 0.03% 287
2017
Q1
$73K Buy
+1,074
New +$75.5K 0.05% 228

Other funds holding GILD

Pinnacle Bancorp's GILD Position: Q1 2026 in Review

Pinnacle Bancorp increased its Gilead Sciences (GILD) stake by 16% in Q1 2026, buying an estimated $18.1K and bringing the position to 958 shares worth $134K. The position accounts for 0.04% of the portfolio, ranked #291.

Pinnacle Bancorp first reported a position in GILD in Q1 2017 and has held it in 31 quarters since. The position peaked at $149K in Q2 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Pinnacle Bancorp held 958 shares of Gilead Sciences worth $134K as of Q1 2026.
  • Pinnacle Bancorp bought 129 Gilead Sciences shares in Q1 2026, an estimated $18.1K.
  • Gilead Sciences made up 0.04% of Pinnacle Bancorp's portfolio in Q1 2026, its #291 holding.
  • Pinnacle Bancorp first reported a position in Gilead Sciences in Q1 2017 and has held it in 31 quarters since.
  • Pinnacle Bancorp's Gilead Sciences position peaked at $149K in Q2 2023.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pinnacle Bancorp's 13F filing for Q1 2026, filed 22 Apr 2026.